OBJECTIVE: The factors responsible for radiographic severity in African American patients with rheumatoid arthritis (RA) are poorly understood. We sought to identify genes whose expression in peripheral blood mononuclear cells is associated with radiographic severity in RA. METHODS: In the first phase of the study, we performed real-time quantitative polymerase chain reaction to analyze the expression of 182 candidate genes in 40 African American RA patients with extremes of radiographic damage (low versus high radiographic scores) and disease duration (≤2 years versus >2 years) and 20 healthy African American control subjects; the genes were selected based on plausible immune pathways. In the second phase, we analyzed the expression of the genes that were shown to be significantly associated with radiographic scores in 576 African American patients with RA and 51 African American control subjects who had not been studied previously, accounting for autoantibody status and disease duration. RESULTS: We observed significant differences in IFNGR1 expression between patients with RA and control subjects (adjusted P [P(adj)] = 6 × 10(-14)) and in IFNGR2 expression between RA patients with erosions and those with no erosions (P(adj) = 0.01 by Wilcoxon's rank sum test). We also observed significant correlations between IFNGR2 expression and radiographic scores (P(adj) = 0.03 for erosions, P(adj) = 0.04 for joint space narrowing, and P(adj) = 0.03 for total radiographic score [zero-inflated negative binomial regression model]) and annualized progression rate (P(adj) = 0.0024 by Spearman's correlation analysis). CONCLUSION: These findings have important implications with respect to the role of interferon-γ (IFNγ) in the pathogenesis of RA and may lead to identification of a biomarker for radiographic damage. Additional studies are needed to define the cell subsets responsible for the association of IFNγ receptor gene expression with radiographic findings, which downstream mechanisms are involved, and generalizability to other RA populations.
OBJECTIVE: The factors responsible for radiographic severity in African American patients with rheumatoid arthritis (RA) are poorly understood. We sought to identify genes whose expression in peripheral blood mononuclear cells is associated with radiographic severity in RA. METHODS: In the first phase of the study, we performed real-time quantitative polymerase chain reaction to analyze the expression of 182 candidate genes in 40 African American RApatients with extremes of radiographic damage (low versus high radiographic scores) and disease duration (≤2 years versus >2 years) and 20 healthy African American control subjects; the genes were selected based on plausible immune pathways. In the second phase, we analyzed the expression of the genes that were shown to be significantly associated with radiographic scores in 576 African American patients with RA and 51 African American control subjects who had not been studied previously, accounting for autoantibody status and disease duration. RESULTS: We observed significant differences in IFNGR1 expression between patients with RA and control subjects (adjusted P [P(adj)] = 6 × 10(-14)) and in IFNGR2 expression between RApatients with erosions and those with no erosions (P(adj) = 0.01 by Wilcoxon's rank sum test). We also observed significant correlations between IFNGR2 expression and radiographic scores (P(adj) = 0.03 for erosions, P(adj) = 0.04 for joint space narrowing, and P(adj) = 0.03 for total radiographic score [zero-inflated negative binomial regression model]) and annualized progression rate (P(adj) = 0.0024 by Spearman's correlation analysis). CONCLUSION: These findings have important implications with respect to the role of interferon-γ (IFNγ) in the pathogenesis of RA and may lead to identification of a biomarker for radiographic damage. Additional studies are needed to define the cell subsets responsible for the association of IFNγ receptor gene expression with radiographic findings, which downstream mechanisms are involved, and generalizability to other RA populations.
Authors: H Nakashima; H Inoue; M Akahoshi; Y Tanaka; K Yamaoka; E Ogami; S Nagano; Y Arinobu; H Niiro; T Otsuka; Y Niho Journal: FEBS Lett Date: 1999-06-18 Impact factor: 4.124
Authors: S Louis Bridges; Zenoria L Causey; Paula I Burgos; B Quynh N Huynh; Laura B Hughes; Maria I Danila; Amalia van Everdingen; Stephanie Ledbetter; Doyt L Conn; Ashutosh Tamhane; Andrew O Westfall; Beth L Jonas; Leigh F Callahan; Edwin A Smith; Richard Brasington; Larry W Moreland; Graciela S Alarcón; Désirée M van der Heijde Journal: Arthritis Care Res (Hoboken) Date: 2010-05 Impact factor: 4.794
Authors: Richard J Reynolds; Xiangqin Cui; Laura K Vaughan; David T Redden; Zenoria Causey; Elizabeth Perkins; Tishi Shah; Laura B Hughes; Aarti Damle; Marlena Kern; Peter K Gregersen; Martin R Johnson; S Louis Bridges Journal: Rheumatol Int Date: 2012-01-12 Impact factor: 2.631
Authors: Yukinori Okada; Di Wu; Gosia Trynka; Towfique Raj; Chikashi Terao; Katsunori Ikari; Yuta Kochi; Koichiro Ohmura; Akari Suzuki; Shinji Yoshida; Robert R Graham; Arun Manoharan; Ward Ortmann; Tushar Bhangale; Joshua C Denny; Robert J Carroll; Anne E Eyler; Jeffrey D Greenberg; Joel M Kremer; Dimitrios A Pappas; Lei Jiang; Jian Yin; Lingying Ye; Ding-Feng Su; Jian Yang; Gang Xie; Ed Keystone; Harm-Jan Westra; Tõnu Esko; Andres Metspalu; Xuezhong Zhou; Namrata Gupta; Daniel Mirel; Eli A Stahl; Dorothée Diogo; Jing Cui; Katherine Liao; Michael H Guo; Keiko Myouzen; Takahisa Kawaguchi; Marieke J H Coenen; Piet L C M van Riel; Mart A F J van de Laar; Henk-Jan Guchelaar; Tom W J Huizinga; Philippe Dieudé; Xavier Mariette; S Louis Bridges; Alexandra Zhernakova; Rene E M Toes; Paul P Tak; Corinne Miceli-Richard; So-Young Bang; Hye-Soon Lee; Javier Martin; Miguel A Gonzalez-Gay; Luis Rodriguez-Rodriguez; Solbritt Rantapää-Dahlqvist; Lisbeth Arlestig; Hyon K Choi; Yoichiro Kamatani; Pilar Galan; Mark Lathrop; Steve Eyre; John Bowes; Anne Barton; Niek de Vries; Larry W Moreland; Lindsey A Criswell; Elizabeth W Karlson; Atsuo Taniguchi; Ryo Yamada; Michiaki Kubo; Jun S Liu; Sang-Cheol Bae; Jane Worthington; Leonid Padyukov; Lars Klareskog; Peter K Gregersen; Soumya Raychaudhuri; Barbara E Stranger; Philip L De Jager; Lude Franke; Peter M Visscher; Matthew A Brown; Hisashi Yamanaka; Tsuneyo Mimori; Atsushi Takahashi; Huji Xu; Timothy W Behrens; Katherine A Siminovitch; Shigeki Momohara; Fumihiko Matsuda; Kazuhiko Yamamoto; Robert M Plenge Journal: Nature Date: 2013-12-25 Impact factor: 49.962
Authors: Maria I Danila; Vincent Albert Laufer; Richard J Reynolds; Qi Yan; Nianjun Liu; Peter K Gregersen; Annette Lee; Marlena Kern; Carl D Langefeld; Donna K Arnett; S Louis Bridges Journal: Mol Med Date: 2017-06-29 Impact factor: 6.354
Authors: Vincent A Laufer; Hemant K Tiwari; Richard J Reynolds; Maria I Danila; Jelai Wang; Jeffrey C Edberg; Robert P Kimberly; Leah C Kottyan; John B Harley; Ted R Mikuls; Peter K Gregersen; Devin M Absher; Carl D Langefeld; Donna K Arnett; S Louis Bridges Journal: Hum Mol Genet Date: 2019-03-01 Impact factor: 6.150
Authors: Amanda McGovern; Stefan Schoenfelder; Paul Martin; Jonathan Massey; Kate Duffus; Darren Plant; Annie Yarwood; Arthur G Pratt; Amy E Anderson; John D Isaacs; Julie Diboll; Nishanthi Thalayasingam; Caroline Ospelt; Anne Barton; Jane Worthington; Peter Fraser; Stephen Eyre; Gisela Orozco Journal: Genome Biol Date: 2016-11-01 Impact factor: 13.583
Authors: Raquel E Reinbolt; Stephen Sonis; Cynthia D Timmers; Juan Luis Fernández-Martínez; Ana Cernea; Enrique J de Andrés-Galiana; Sepehr Hashemi; Karin Miller; Robert Pilarski; Maryam B Lustberg Journal: Cancer Med Date: 2017-11-23 Impact factor: 4.452
Authors: Jason Ptacek; Rachael E Hawtin; Dongmei Sun; Brent Louie; Erik Evensen; Barbara B Mittleman; Alessandra Cesano; Guy Cavet; Clifton O Bingham; Stacey S Cofield; Jeffrey R Curtis; Maria I Danila; Chander Raman; Richard A Furie; Mark C Genovese; William H Robinson; Marc C Levesque; Larry W Moreland; Peter A Nigrovic; Nancy A Shadick; James R O'Dell; Geoffrey M Thiele; E William St Clair; Christopher C Striebich; Matthew B Hale; Houman Khalili; Franak Batliwalla; Cynthia Aranow; Meggan Mackay; Betty Diamond; Garry P Nolan; Peter K Gregersen; S Louis Bridges Journal: PLoS One Date: 2021-01-14 Impact factor: 3.240
Authors: Vishal Sharma; Brandon J Pope; Nathan V Santiago; Molly T Boland; Dongmei Sun; Richard J Reynolds; Alexander J Szalai; S Louis Bridges; Chander Raman Journal: ACR Open Rheumatol Date: 2021-03-28
Authors: Dongmei Sun; Thanh M Nguyen; Robert J Allaway; Jelai Wang; Verena Chung; Thomas V Yu; Michael Mason; Isaac Dimitrovsky; Lars Ericson; Hongyang Li; Yuanfang Guan; Ariel Israel; Alex Olar; Balint Armin Pataki; Gustavo Stolovitzky; Justin Guinney; Percio S Gulko; Mason B Frazier; Jake Y Chen; James C Costello; S Louis Bridges Journal: JAMA Netw Open Date: 2022-08-01